Alyami Fahad, Farhat Walid, Figueroa Victor H, Romao Rodrigo L P
Division of Pediatric Urology, Department of Surgery, University of Toronto; The Hospital for Sick Children, Toronto, ON.
Can Urol Assoc J. 2014 Sep;8(9-10):E615-8. doi: 10.5489/cuaj.2190.
Uroflowmetry (UF) is frequently employed in daily pediatric urology practice for diagnostic and follow-up purposes. We assess the utility and cost-effectiveness of UF in the management of patients seen at a tertiary care centre.
We retrospectively reviewed the charts of consecutive patients who had a UF between January 1, 2010 and March 31, 2010. We collected data on demographics, diagnosis, UF parameters and the impact of the UF on management. The impact on management was defined as indication for surgery, introduction of new medications and bladder retraining based on clinical and UF findings.
In total, 524 patients were included in the study. In 63 (12%) patients, UF was performed as part of the evaluation at the first clinic appointment. The most common diagnoses were voiding dysfunction (VD) 41%, hypospadias 26%, vesicoureteric reflux (VUR) 16%, monosymptomatic nocturnal enuresis (NE) 8%, posterior urethral valves 5% and meatal stenosis (MS) 4%. In the VD group, UF contributed to a management decision in 25.2% of patients. In the MS group, surgical intervention was based on symptoms and supported by the UF in 41% of patients; in the PUV group, 50% of patients demonstrated high (>20 cc) post-void residual, which aided in management decisions. In contrast, there were virtually no changes in management supported by the UF in the NE, VUR and hypospadias groups. Overall, UF parameters had a direct influence in the management decisions in only 67 (12.8%) patients. Nonetheless, a repeat test was ordered for 44.5% of patients.
In an era of financial restraints and in a busy tertiary pediatric urology practice, judicious use of UF for specific indications may translate into a more cost-effective use of time and resources. As expected, patients with VD were the ones that benefited most from the test, as did patients with symptomatic MS and PUV.
尿流率测定(UF)在日常儿科泌尿外科实践中常用于诊断和随访目的。我们评估了尿流率测定在三级医疗中心对患者管理的实用性和成本效益。
我们回顾性分析了2010年1月1日至2010年3月31日期间连续进行尿流率测定的患者病历。我们收集了人口统计学、诊断、尿流率测定参数以及尿流率测定对管理的影响等数据。对管理的影响定义为基于临床和尿流率测定结果的手术指征、新药引入和膀胱再训练。
本研究共纳入524例患者。其中63例(12%)患者在首次门诊评估时进行了尿流率测定。最常见的诊断为排尿功能障碍(VD)41%、尿道下裂26%、膀胱输尿管反流(VUR)16%、单纯性夜间遗尿(NE)8%、后尿道瓣膜5%和尿道口狭窄(MS)4%。在VD组中,尿流率测定有助于25.2%的患者做出管理决策。在MS组中,41%的患者手术干预基于症状且得到尿流率测定的支持;在PUV组中,50%的患者排尿后残余尿量高(>20 cc),这有助于做出管理决策。相比之下,在NE、VUR和尿道下裂组中,尿流率测定几乎未对管理产生改变。总体而言,尿流率测定参数仅对67例(12.8%)患者的管理决策有直接影响。尽管如此,44.�%的患者被要求进行重复检测。
在财政紧张的时代以及繁忙的儿科泌尿外科实践中,明智地将尿流率测定用于特定指征可能会更具成本效益地利用时间和资源。正如预期的那样,VD患者以及有症状的MS和PUV患者从该检测中获益最大。